Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.
about
Child with atopic dermatitisFilaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virusGenetic and epigenetic studies of atopic dermatitisAdvances in atopic dermatitisRecent insights into atopic dermatitis and implications for management of infectious complications.Associations of filaggrin gene loss-of-function variants and human papillomavirus-related cancer and pre-cancer in Danish adults.Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis.The infectious aspects of atopic dermatitis.CD14, a key candidate gene associated with a specific immune response to cockroachGenetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma.Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls.Tight junction defects in patients with atopic dermatitis.Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitisNatural history and risk factors of atopic dermatitis in childrenThe signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.Epidermal barrier in atopic dermatitis.An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum.Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.Skin barrier disruption: a requirement for allergen sensitization?One remarkable molecule: filaggrin.Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum.Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: a potential predictive biomarker for high risk of Eczema herpeticum.Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.Assessment of the association between atopic conditions and tympanostomy tube placement in children.Staphylococcus aureus α-toxin modulates skin host response to viral infection.Comorbidity in Atopic Dermatitis.Why is eczema herpeticum unexpectedly rare?Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication.Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects.Atopic dermatitis: the role of Langerhans cells in disease pathogenesis.Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century.Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine.
P2860
Q26830792-2CE3E37A-AE6D-4964-88A5-DAA3798DE0D9Q27310377-323F1FF5-9FF7-4AB9-A51E-2570EDD48C94Q28073454-E203E8A9-C4E0-45A7-86A1-BCAD820CF13EQ33352382-CE82A398-974C-4005-B472-A121FDE57B99Q33621496-6CE2D5A2-A072-4D55-98A4-184526AD2ECEQ33721547-B4849181-71F3-4D10-A534-DFBF1985E9B2Q33877517-02FA1604-C29B-49CF-9396-39B89C5578AFQ34032522-D9F0848F-BE67-4172-A626-D7DC656D62EBQ34063320-A070CFF2-2EB3-4777-84B5-C277EFD58EACQ34078819-6FA5A0F7-E98C-4FB5-9EE8-A259C4C82F8FQ34294746-7D306C40-42FE-4F99-9FCD-54142CC27C93Q34303315-1B27CF1A-5891-4C6B-8631-19F29BEF3621Q34329191-477168C1-2193-4466-8AF1-6040B8247C4BQ34388371-CB785A82-369C-4EB1-B031-4847080F2EEFQ34629278-065E4F30-1C1C-45A9-8D08-065C1F8B3FF7Q34686545-0627F983-33FB-4329-905E-32B07B3D6D7BQ34781786-6C0D800B-0F2B-424B-A585-981AF2C8304AQ35065037-ABC61272-8A09-4D5F-AAC5-1FC878AA623CQ35085856-B84A927F-75FE-4AAA-9CA4-224F6E55A32AQ35123892-832123AF-9589-48F3-92AD-15AF23CB75CCQ35490893-36FD1077-45D2-4F86-B278-DC5782E0C31FQ35622183-EECB266D-F5F3-43AD-9DF3-502043CF9E73Q35741426-2688D5E7-505D-4E34-B04F-55AAECE4C384Q35754287-04485306-67B5-4DCF-B118-4A6F38A1054CQ35757285-8F2899AB-EA1D-41D1-94E1-0FFA508BCF52Q36043328-217A844B-2275-4FA4-909B-ED6976ABA2D9Q36071198-1E67BB92-37D8-4CCE-B200-4C859AF209B4Q36108363-AF6F3F74-E61A-4A85-8370-CFE100C0CD4FQ36172617-F263B5DE-6D9B-4D1B-83BF-2C42635995C7Q36372787-21509250-BD5A-42F4-B48E-A2D42D7AC140Q36375783-B0EA6B18-17CA-43C4-8E22-9D387172206DQ36676808-4A159625-E6D9-44CF-B608-0EE28A62D149Q36899783-EA98A841-6741-47A8-B984-DBCA52D4BCEBQ37173732-11399CE0-BBC9-444D-B207-DBEEE78327B3Q37175410-C9898863-2178-41D1-A4B8-3D03C9587685Q37203388-6D8F08F9-8C05-43C2-B7C0-9C64D64152F3Q37619379-E04D02AB-84C9-44DE-B6E9-BC1E55B2C1B3Q37721153-B51B9703-AD4A-472D-8D96-9C134EAEB181Q37962982-486EA57B-86F1-4BC1-9437-450152172BE0Q38056156-9F08E707-D83C-447C-8113-896E9045F484
P2860
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@en
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@nl
type
label
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@en
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@nl
prefLabel
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@en
Filaggrin mutations that confe ...... er risk for eczema herpeticum.
@nl
P2093
P2860
P1476
Filaggrin mutations that confe ...... ter risk for eczema herpeticum
@en
P2093
Donald Y M Leung
Jon M Hanifin
Kathleen C Barnes
Lisa A Beck
Lynda Schneider
Mark Boguniewicz
Nicholas M Rafaels
Pei-Song Gao
Tanda Murray
P2860
P304
507-13, 513.e1-7
P356
10.1016/J.JACI.2009.07.034
P407
P577
2009-09-01T00:00:00Z